ArticleFrontiers in pharmacology2016

OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.

Hany A Omar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.